BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 378855)

  • 1. Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations.
    Riottot M; Fournier JM; Pillot J
    Infect Immun; 1979 May; 24(2):476-82. PubMed ID: 378855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations.
    Riottot MM; Fournier JM; Jouin H
    Infect Immun; 1981 Jan; 31(1):71-7. PubMed ID: 7012008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine immunoprotective activity of Klebsiella pneumoniae cell surface preparations: comparative study with ribosomal preparations.
    Fournier JM; Jolivet-Reynaud C; Riottot MM; Jouin H
    Infect Immun; 1981 May; 32(2):420-6. PubMed ID: 7019071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoprotective activity of capsular polysaccharide in Klebsiella pneumoniae ribosomal preparations does not involve ribonucleic acid.
    Riottot MM; Fournier JM
    Infect Immun; 1981 Oct; 34(1):126-30. PubMed ID: 6170582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An attempt to localize the vaccinating power of Klebsiella pneumoniae ribosomal preparations using saccharose-gradient ultracentrifugation.
    Robert D; Bienvenu P; Lafont S; Jouanneteau B; Normier G; Dussourd D'Hinterland L; Fontanges R
    Microbiol Immunol; 1982; 26(10):941-50. PubMed ID: 6761558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the polysaccharide and of the lipopolysaccharide in the immunoprotective capacity of Klebsiella pneumoniae ribosomes.
    Robert D; Normier G; Lafont S; Dussourd d'Hinterland L; Fontanges R; Wigzell H
    Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):293-9. PubMed ID: 6393710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic properties of Klebsiella pneumoniae type 2 capsular polysaccharide.
    Robert A; Jouin H; Fournier JM
    Infect Immun; 1986 Nov; 54(2):365-70. PubMed ID: 3095240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the immunogenicity of ribosomes and ribosomal proteins isolated from Klebsiella pneumoniae and Streptococcus pneumoniae.
    Robert D; Michel S; Ivanoff B; Cozzone AJ; Fontanges R
    Microbiol Immunol; 1981; 25(2):183-94. PubMed ID: 7015078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antigenic similarity between polysaccharide and ribosomal vaccine extracts from Klebsiella pneumonia].
    Robert D; Lafont S; Bienvenu P; Normier G; Dussourd D'Hinterland L; Fontanges R
    C R Seances Acad Sci III; 1981 Jan; 292(3):281-4. PubMed ID: 6162585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribosomes as carriers for antigenic determinants of the surface of micro-organisms.
    Normier G; Pinel AM; Dussourd d'Hinterland L; Wigzell H; Binz H
    Dev Biol Stand; 1992; 77():79-85. PubMed ID: 1385236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1984 Jul; 45(1):139-42. PubMed ID: 6376353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical properties of oligosaccharide-protein conjugates with Klebsiella-K2-specificity. II. Protective capacity of the conjugates and anti-conjugate antibodies against infection with Klebsiella pneumoniae 01:K2 in mice.
    Geyer H; Schlecht S; Himmelspach K
    Med Microbiol Immunol; 1982; 171(3):135-43. PubMed ID: 6186899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of antibodies against outer-membrane proteins in murine resistance to infection with encapsulated Klebsiella pneumoniae.
    Serushago BA; Mitsuyama M; Handa T; Koga T; Nomoto K
    J Gen Microbiol; 1989 Aug; 135(8):2259-68. PubMed ID: 2699330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the mode of action of ribosomal vaccines from Klebsiella and Streptococcus pneumoniae and their ribonucleic and protein fractions using passive immunization.
    Robert D; Ivanoff B; Fontanges R; Normier G; Pinel AM; Dussourd D'Hinterland L
    Microbiol Immunol; 1982; 26(10):933-40. PubMed ID: 6186896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization against fatal experimental Klebsiella pneumoniae pneumonia.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1986 Nov; 54(2):403-7. PubMed ID: 3533779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial ribosomal vaccines.
    Gregory RL
    Rev Infect Dis; 1986; 8(2):208-17. PubMed ID: 3518022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of an extracellular toxic complex by various strains of Klebsiella pneumoniae.
    Straus DC
    Infect Immun; 1987 Jan; 55(1):44-8. PubMed ID: 3539806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.
    Clements A; Jenney AW; Farn JL; Brown LE; Deliyannis G; Hartland EL; Pearse MJ; Maloney MB; Wesselingh SL; Wijburg OL; Strugnell RA
    Vaccine; 2008 Oct; 26(44):5649-53. PubMed ID: 18725260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A murine monoclonal antibody against Klebsiella capsular polysaccharide is opsonic in vitro and protects against experimental Klebsiella pneumoniae infection.
    Trautmann M; Cryz SJ; Sadoff JC; Cross AS
    Microb Pathog; 1988 Sep; 5(3):177-87. PubMed ID: 3063912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human monoclonal antibodies specific for capsular polysaccharides of Klebsiella recognize clusters of multiple serotypes.
    Lang AB; Bruderer U; Senyk G; Pitt TL; Larrick JW; Cryz SJ
    J Immunol; 1991 May; 146(9):3160-4. PubMed ID: 2016541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.